Ahmed Haddad

Ahmed Haddad practices at Riverside Medical Clinic in Riverside, California.

Ahmed Haddad's NPI, 1700297728, was assigned on May 13, 2014. Ahmed Haddad graduated from University of Sheffield School of Medicine in 1997. Ahmed Haddad holds California license C170790.

Ahmed Haddad's primary practice is Riverside Medical Clinic, at 19314 Jesse Ln, Riverside, CA 92508 in Riverside County. The practice phone is (951) 683-6370.

Ahmed Haddad's primary practice is Riverside Medical Clinic in Riverside, California. Ahmed Haddad is also affiliated with Riverside Community Hospital. The medical group on file is Riverside Medical Clinic. Dmand AI also links Ahmed Haddad to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ahmed Haddad practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Ahmed Haddad's primary specialty in the NPI Registry, under taxonomy code 208800000X. Ahmed Haddad is board certified in urology by the American Board of Urology. Dmand AI has Ahmed Haddad's licenses on file in 3 states: California, Texas and Kentucky.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Ahmed Haddad treats.

CMS data shows 922 Medicare services from Ahmed Haddad across 11 procedure codes in 2024, for 346 Medicare patients. Medicare paid $68,597 for them.

CMS counts 346 Medicare patients who saw Ahmed Haddad in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ahmed Haddad's median patient age at 65, with 22% women.

In 2024, Ahmed Haddad wrote 2,145 Medicare Part D claims for 680 patients. 92% of them were for generic drugs. CMS names the drug for 1,984 of them, across 24 drugs with 11 or more claims each, at $897,447 in total drug cost. In 2023, CMS named 1,376 claims across 22 drugs.

Ahmed Haddad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ahmed Haddad as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 31 papers to Ahmed Haddad, published from 2007 to 2024. 2015 was the busiest year, with 7. The most frequent topics are Kidney Neoplasms, Carcinoma, Renal Cell and Biomarkers, Tumor. Ahmed Haddad has published most often in Urol Oncol. Ahmed Haddad's most frequent co-authors are Yair Lotan, MD, Vitaly Margulis, MD and Arthur Isaac Sagalowsky, MD.

CMS Open Payments shows 170 general payments to Ahmed Haddad from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Astellas Pharma US Inc paid the most, $975.

Ahmed Haddad graduated from University of Sheffield School of Medicine in 1997.

Ahmed Haddad is in network with 15 carriers, including Aetna, United Healthcare and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.